Literature DB >> 34133861

The Evolving Challenge of Infections in Cirrhosis.

Jasmohan S Bajaj1, Patrick S Kamath1, K Rajender Reddy1.   

Abstract

Entities:  

Year:  2021        PMID: 34133861     DOI: 10.1056/NEJMra2021808

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

Review 1.  Clostridioides difficile Infection in Liver Cirrhosis: A Concise Review.

Authors:  Yuanbin Liu; Mingkai Chen
Journal:  Can J Gastroenterol Hepatol       Date:  2022-06-07

2.  Hepatic pannexin-1 mediates ST2+ regulatory T cells promoting resolution of inflammation in lipopolysaccharide-induced endotoxemia.

Authors:  Pusen Wang; Baojie Shi; Chunguang Wang; Yuanyuan Wang; Weitao Que; Zhongyi Jiang; Xueni Liu; Qianwei Jiang; Hao Li; Zhihai Peng; Lin Zhong
Journal:  Clin Transl Med       Date:  2022-05

Review 3.  Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb®-Basics, Indications and Perspectives-A Scoping Review.

Authors:  Thomas Köhler; Elke Schwier; Janina Praxenthaler; Carmen Kirchner; Dietrich Henzler; Claas Eickmeyer
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 5.923

4.  Multiple bacterial virulence factors focused on adherence and biofilm formation associate with outcomes in cirrhosis.

Authors:  Jasmohan S Bajaj; Amirhossein Shamsaddini; Chathur Acharya; Andrew Fagan; Masoumeh Sikaroodi; Edith Gavis; Sara McGeorge; Alexander Khoruts; Michael Fuchs; Richard K Sterling; Hannah Lee; Patrick M Gillevet
Journal:  Gut Microbes       Date:  2021 Jan-Dec

Review 5.  Prevalence and Therapeutic Management of Infections by Multi-Drug-Resistant Organisms (MDROs) in Patients with Liver Cirrhosis: A Narrative Review.

Authors:  Lorenzo Onorato; Caterina Monari; Salvatore Capuano; Pierantonio Grimaldi; Nicola Coppola
Journal:  Antibiotics (Basel)       Date:  2022-02-11

6.  Influence of Metabolic Risk Factors on the Risk of Bacterial Infections in Hepatitis B-Related Cirrhosis: A 10-Year Cohort Study.

Authors:  Qiao Yang; Yifan Tong; Borui Pi; Hong Yu; Fangfang Lv
Journal:  Front Med (Lausanne)       Date:  2022-04-14

7.  Acute decompensation events differentially impact the risk of nosocomial infections and short-term outcomes in patients with cirrhosis.

Authors:  Xianbin Xu; Xia Yu; Kai Gong; Huilan Tu; Junjie Yao; Yan Lan; Shaoheng Ye; Haoda Weng; Yu Shi; Jifang Sheng
Journal:  Front Med (Lausanne)       Date:  2022-08-17

8.  CXCR2 inhibition enables NASH-HCC immunotherapy.

Authors:  Jack Leslie; John B G Mackey; Thomas Jamieson; Erik Ramon-Gil; Thomas M Drake; Frédéric Fercoq; William Clark; Kathryn Gilroy; Ann Hedley; Colin Nixon; Saimir Luli; Maja Laszczewska; Roser Pinyol; Roger Esteban-Fabró; Catherine E Willoughby; Philipp K Haber; Carmen Andreu-Oller; Mohammad Rahbari; Chaofan Fan; Dominik Pfister; Shreya Raman; Niall Wilson; Miryam Müller; Amy Collins; Daniel Geh; Andrew Fuller; David McDonald; Gillian Hulme; Andrew Filby; Xabier Cortes-Lavaud; Noha-Ehssan Mohamed; Catriona A Ford; Ximena L Raffo Iraolagoitia; Amanda J McFarlane; Misti V McCain; Rachel A Ridgway; Edward W Roberts; Simon T Barry; Gerard J Graham; Mathias Heikenwälder; Helen L Reeves; Josep M Llovet; Leo M Carlin; Thomas G Bird; Owen J Sansom; Derek A Mann
Journal:  Gut       Date:  2022-04-27       Impact factor: 31.793

9.  Mortality burden due to liver cirrhosis and hepatocellular carcinoma in Ghana; prevalence of risk factors and predictors of poor in-hospital survival.

Authors:  Yvonne A Nartey; Samuel O Antwi; Ansumana S Bockarie; Lindsey Hiebert; Henry Njuguna; John W Ward; Yaw A Awuku; Amelie Plymoth; Lewis R Roberts
Journal:  PLoS One       Date:  2022-09-13       Impact factor: 3.752

10.  Interprofessional Collaboration between ICU Physicians, Staff Nurses, and Hospital Pharmacists Optimizes Antimicrobial Treatment and Improves Quality of Care and Economic Outcome.

Authors:  Stephan Schmid; Sophie Schlosser; Karsten Gülow; Vlad Pavel; Martina Müller; Alexander Kratzer
Journal:  Antibiotics (Basel)       Date:  2022-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.